Vaccine firms can fool governments – but not the markets
THREE years after the launch of mRNA gene therapy vaccines, all now proven to be both harmful and ineffective, the share prices of all three of the companies involved – BioNTech, Pfizer and Moderna – have plummeted. The invisible hand of the market is acting where governments and regulators refused. Investor confidence matters. The 2023 share price drop shows it is on […]
